Related Experiment Video

Updated: Mar 10, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K

MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma

Elżbieta Boratyn1, Iwona Nowak1, Małgorzata Durbas1

  • 1Faculty of Biochemistry, Biophysics and Biotechnology, Laboratory of Molecular Genetics and Virology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.

Journal of Cellular Biochemistry
|December 10, 2016
PubMed

Insights

MCPIP1 (regnase-1) protein reduces MYCN oncoprotein levels in neuroblastoma by decreasing Akt/mTOR signaling. This finding links MCPIP1 to MYCN regulation and cancer progression, without inducing apoptosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • MCPIP1 (regnase-1) primarily regulates inflammation, with roles in apoptosis and differentiation, but its cancer involvement is under-recognized.
  • MCPIP1 expression is absent in primary neuroblastoma tumors and cell lines, inversely correlating with the oncoprotein MYCN.
  • Previous studies indicated an inverse correlation between MCPIP1 and MYCN in neuroblastoma cells.

Purpose of the Study:

  • To investigate the functional role of MCPIP1 in regulating MYCN expression and stability in neuroblastoma.
  • To elucidate the molecular mechanisms by which MCPIP1 affects MYCN levels and signaling pathways.

Main Methods:

  • Exogenous expression of MCPIP1 protein in neuroblastoma cells.
  • Analysis of MYCN mRNA and protein levels.
  • Assessment of MYCN mRNA half-life.
  • Western blot analysis of MYCN partners and signaling pathway components (Akt/mTOR).
  • Phosphorylation site analysis of MYCN.

Main Results:

  • Exogenous MCPIP1 expression decreased MYCN mRNA and protein levels without altering MYCN mRNA half-life.
  • MCPIP1 affected phosphorylation of MYCN partners and key Akt/mTOR signaling components.
  • Increased MYCN phosphorylation at Thr58, leading to destabilization.
  • MCPIP1 expression did not induce apoptosis.

Conclusions:

  • MCPIP1 regulates MYCN expression and stability by decreasing Akt/mTOR signaling.
  • These findings establish a novel role for MCPIP1 in neuroblastoma, linking it to MYCN regulation.
  • MCPIP1's function in MYCN destabilization offers potential therapeutic insights for neuroblastoma.
Keywords:
AKT/mTOR PATHWAYMCPIP1MYCNNEUROBLASTOMARNase

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.9K